Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Miura K, Takahashi H, Nakagawa M, Hamada T, Uchino Y, Iizuka K, Ohtake S, Iriyama N, Hatta Y, Nakamura H. Miura K, et al. Among authors: hamada t. Expert Rev Anticancer Ther. 2022 Jun;22(6):583-595. doi: 10.1080/14737140.2022.2071262. Epub 2022 May 5. Expert Rev Anticancer Ther. 2022. PMID: 35472312 Review.
Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
Nakayama T, Chuma M, Tochikura N, Iwabuchi S, Suzuki S, Matsumoto C, Imai T, Hamada T, Nakagawa M, Takahashi H, Uchino Y, Miura K, Iriyama N, Hatta Y, Takei M, Kimura T. Nakayama T, et al. Among authors: hamada t. Ther Drug Monit. 2020 Feb;42(1):133-138. doi: 10.1097/FTD.0000000000000678. Ther Drug Monit. 2020. PMID: 31323015
Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma.
Nakagawa M, Iriyama N, Ishikawa T, Miura K, Uchino Y, Takahashi H, Hamada T, Iizuka K, Koike T, Kurihara K, Nakayama T, Hatta Y, Takei M. Nakagawa M, et al. Among authors: hamada t. Cancer Diagn Progn. 2021 Jul 3;1(3):221-229. doi: 10.21873/cdp.10030. eCollection 2021 Jul-Aug. Cancer Diagn Progn. 2021. PMID: 35399319 Free PMC article.
Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma.
Noguchi Y, Iriyama N, Takahashi H, Uchino Y, Nakagawa M, Hamada T, Iizuka K, Koike T, Kurihara K, Endo T, Yoshida T, Miura K, Nakayama T, Hatta Y, Takei M. Noguchi Y, et al. Among authors: hamada t. Cancer Diagn Progn. 2021 May 3;1(2):35-42. doi: 10.21873/cdp.10006. eCollection 2021 May-Jun. Cancer Diagn Progn. 2021. PMID: 35403126 Free PMC article.
2,578 results